News

Numbness in the feet is a symptom of neuropathy or nerve damage, one of the most common long-term complications of type 2 ...
Nerve pain caused by diabetes, known as diabetic peripheral neuropathy, can be severe, constant, and hard to treat.It may start as a tingling feeling, followed by numbness and pain. But there are ...
With our current indications, adults with painful diabetic peripheral neuropathy of the feet and postherpetic neuralgia, we ...
How to contact Medicare for questions about Qutenza coverage. For questions about Qutenza or other pain management coverage, call Medicare at 800-MEDICARE (800-633-4227). TTY users can call 877 ...
Qutenza (capsaicin) may be prescribed for adults to treat neuropathic pain associated with postherpetic neuralgia and for neuropathic pain associated with diabetic peripheral neuropathy. Learn ...
Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
News. UTD scientists solve 100-year-old mystery behind diabetic nerve damage Nageotte nodules, once overlooked, may hold the key to understanding and treating diabetic peripheral neuropathy.
Original Medicare Part B may cover Qutenza (capsaicin) if your doctor prescribes the medication for FDA-approved purposes and the pharmacy you use accepts Medicare. Learn more.
AACHEN, Germany and MORRISTOWN, N.J., Nov. 7, 2024 /PRNewswire/ -- Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical ...